Later, Honda et al. compared the plasma protein profiles of pancreatic cancer patients with those of healthy volunteer through QTOF (quadrupole time-of-flight) MS, and suggested the use of apolipoprotein-AII (APOAII) isoforms (especially APOAII-2) for pancreatic cancer surveillance [121]. This evidence concerns the gene APOA2 and pancreatic neoplasm.